MindImmune Therapeutics, Inc. is a company that specializes in developing novel therapeutics targeting the immune system to treat brain disease. They have made a fundamental discovery that implicates the peripheral immune system in the pathology of Alzheimer's disease and are developing a therapeutic antibody to block the immune attack on the brain.
No recent news for this company.